What is he best known for?
The fields of study he is best known for:
His main research concerns Genetics, Alzheimer's disease, Locus, Gene and Degenerative disease.
His work on Age of onset expands to the thematically related Genetics.
His Alzheimer's disease research integrates issues from Dementia, Physiology and Genetic testing.
Thomas D. Bird works mostly in the field of Locus, limiting it down to topics relating to Charcot-Marie-Tooth Disease Type 1A and, in certain cases, Peripheral myelin protein 22, as a part of the same area of interest.
The various areas that he examines in his Degenerative disease study include Genetic determinism and Progressive supranuclear palsy.
His Mutation research is multidisciplinary, incorporating perspectives in Molecular biology, Microtubule, Neuroscience and Exon.
His most cited work include:
- Candidate gene for the chromosome 1 familial Alzheimer's disease locus (2222 citations)
- Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease (1385 citations)
- Tau is a candidate gene for chromosome 17 frontotemporal dementia. (1149 citations)
What are the main themes of his work throughout his whole career to date?
Thomas D. Bird spends much of his time researching Genetics, GeneReviews, Pathology, Internal medicine and Disease.
His is doing research in Locus, Gene, Mutation, Genetic linkage and Allele, both of which are found in Genetics.
His studies deal with areas such as Genetic heterogeneity and Gene mapping as well as Locus.
His research in Allele intersects with topics in Apolipoprotein E and Genotype.
Thomas D. Bird interconnects Dermatology, Molecular biology and Pediatrics in the investigation of issues within GeneReviews.
His Internal medicine research includes elements of Gastroenterology and Endocrinology.
He most often published in these fields:
- Genetics (38.65%)
- GeneReviews (30.45%)
- Pathology (19.33%)
What were the highlights of his more recent work (between 2014-2021)?
- GeneReviews (30.45%)
- Internal medicine (14.61%)
- Pediatrics (10.00%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in GeneReviews, Internal medicine, Pediatrics, Pathology and Dermatology.
His GeneReviews research entails a greater understanding of Genetics.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
All of his Pathology and Spinocerebellar ataxia and Neuropathology investigations are sub-components of the entire Pathology study.
Between 2014 and 2021, his most popular works were:
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (429 citations)
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy (304 citations)
- Actionable exomic incidental findings in 6503 participants: challenges of variant classification (233 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
